LFB BIOMANUFACTURING

manufactures monoclonal antibodies and recombinant proteins through cell culture

Cell line development

Process development and scale-up

Manufacturing of clinical and commercial batches

LFB BIOMANUFACTURING,

an LFB group company, is a CDMO

EMABling®,

our platform for monoclonal antibodies

Cutting-edge know how

Single use technologies

X 3 our production capacity increase

from 2017

06 Apr 2020 LFB GROUP

LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa

15 Apr 2020 Biomanu-facturing

LFB SIGNS AGREEMENT WITH XENOTHERA TO MANUFACTURE FIRST CLINICAL BATCH OF XENOTHERA'S XAV-19 FOR THE TREATMENT OF CORONAVIRUS INFECTIONS INCLUDING COVID-19

10 Oct 2019 Biomanu-facturing

Festival of Biologics 2019, 15 - 17 October

30 Apr 2019 Biomanu-facturing

LFB Biomanufacturing present at BioTalk 2019 in Boston May 22nd and 23rd

All news